advertisement
Oh S 8
Showing records 1 to 8 | Display all abstracts from Oh S117263 Effects of Topical Anti-Glaucoma Medications on Outcomes of Endoscopic Dacryocystorhinostomy: Comparison with Age- and Sex-Matched Controls
Lee SE
Journal of clinical medicine 2024; 13:
118900 Perioperative Management in Patients with Atrial Fibrillation Treated with Non-Vitamin K Antagonist Oral Anticoagulants Undergoing Minor Bleeding Risk Procedure: Rationale and Protocol for the PERIXa Study
Kwon S
Vascular health and risk management 2024; 20: 231-244
117263 Effects of Topical Anti-Glaucoma Medications on Outcomes of Endoscopic Dacryocystorhinostomy: Comparison with Age- and Sex-Matched Controls
Lim HB
Journal of clinical medicine 2024; 13:
118900 Perioperative Management in Patients with Atrial Fibrillation Treated with Non-Vitamin K Antagonist Oral Anticoagulants Undergoing Minor Bleeding Risk Procedure: Rationale and Protocol for the PERIXa Study
Lee SR; Choi EK
Vascular health and risk management 2024; 20: 231-244
117263 Effects of Topical Anti-Glaucoma Medications on Outcomes of Endoscopic Dacryocystorhinostomy: Comparison with Age- and Sex-Matched Controls
Oh S
Journal of clinical medicine 2024; 13:
118900 Perioperative Management in Patients with Atrial Fibrillation Treated with Non-Vitamin K Antagonist Oral Anticoagulants Undergoing Minor Bleeding Risk Procedure: Rationale and Protocol for the PERIXa Study
Lee KY
Vascular health and risk management 2024; 20: 231-244
117263 Effects of Topical Anti-Glaucoma Medications on Outcomes of Endoscopic Dacryocystorhinostomy: Comparison with Age- and Sex-Matched Controls
Lee K; Lee SB
Journal of clinical medicine 2024; 13:
118900 Perioperative Management in Patients with Atrial Fibrillation Treated with Non-Vitamin K Antagonist Oral Anticoagulants Undergoing Minor Bleeding Risk Procedure: Rationale and Protocol for the PERIXa Study
Choi J; Ahn HJ; Oh S; Lip GYH
Vascular health and risk management 2024; 20: 231-244
